Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Explore a Topic

Lipid Disorders

Lipoprotein Particles and PAD in Women, Circulation; ePub 2018 Aug 31; Aday, et al

Long-Term LDL-C and CV Mortality Risk, Circulation; ePub 2018 Aug 16; Abdullah, et al

Read more in Lipid Disorders

Pediatrics

Lead Exposure & BP Trends in Children, Am J Cardiol; ePub 2018 Sep 7; Zachariah, et al

BP Targets During Pediatric In-Hospital CPR, Circulation; ePub 2017 Dec 26; Berg, et al

Read more in Pediatrics

Practice Management

Therapeutic Patient Education for CV Self-Management , Circ Cardiovasc Qual Outcomes; ePub 2017 Jun 19; Barnason, et al

Can Women with CHD Have Safe Pregnancies?, Circulation; ePub 2017 Jan 12; Canobbio, et al

Read more in Practice Management

Preventive Care

Liraglutide & CV Events in Patients with T2D & CKD, Circulation; ePub 2018 Oct 3; Mann, et al

Does Aspirin Prevent CV Events in Older Adults?, N Engl J Med; ePub 2018 Sep 16; McNeil, et al

Read more in Preventive Care

Stroke

Seasonal Patterns of Stroke in the US, J Am Heart Assoc; ePub 2018 Nov 16; Chu, et al

Liraglutide & CV Events in Patients with T2D & CKD, Circulation; ePub 2018 Oct 3; Mann, et al

Read more in Stroke

Thrombosis

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Efficacy of NOACs in Patients with AF and VHD, J Am Heart Assoc; ePub 2018 Apr 5; Briasoulis, et al

Read more in Thrombosis

Pages

Latest Must Reads

Trends in LDL-C and 2013 Treatment Guidelines, Clin Cardiol; ePub 2018 Nov 15; Superko, et al

PCSK9 Inhibitors Reduce Risk of CV Events, Nat Rev Cardiol; ePub 2018 Nov 12; Sabatine, et al

Risk Factors for CVD in Heterozygous FH, J Clin Lipidol; ePub 2018 Nov 7; Akioyamen, et al

Hypercholesterolemia Patients on Suboptimal Statins, J Atheroscler Thromb; ePub 2018 Oct 26; Kajinami, et al

Cholesterol Guidelines Stress Lifetime Approach, Circulation; ePub 2018 Nov 10; Grundy, et al